These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8158169)

  • 1. Naturally occurring antiacne agents.
    Kubo I; Muroi H; Kubo A
    J Nat Prod; 1994 Jan; 57(1):9-17. PubMed ID: 8158169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibiotic susceptibility of Propionibacterium acnes: a 15-year bacteriological study and retrospective evaluation.
    Kurokawa I; Nishijima S; Asada Y
    J Dermatol; 1988 Apr; 15(2):149-54. PubMed ID: 2971698
    [No Abstract]   [Full Text] [Related]  

  • 4. Metronidazole, its bioactive metabolites and acne.
    Bannatyne RM
    Curr Med Res Opin; 1999; 15(4):298-9. PubMed ID: 10640262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial and anti-inflammatory effects of Jeju medicinal plants against acne-inducing bacteria.
    Kim SS; Kim JY; Lee NH; Hyun CG
    J Gen Appl Microbiol; 2008 Apr; 54(2):101-6. PubMed ID: 18497484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.
    Vogt K; Hermann J; Blume U; Gollnick H; Hahn H; Haustein UF; Orfanos CE
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):943-5. PubMed ID: 1486893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro evaluation of marine derived fungi against Cutibacterium acnes.
    Agrawal S; Adholeya A; Barrow CJ; Deshmukh SK
    Anaerobe; 2018 Feb; 49():5-13. PubMed ID: 29100929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical composition and biological activities of Jeju Thymus quinquecostatus essential oils against Propionibacterium species inducing acne.
    Oh TH; Kim SS; Yoon WJ; Kim JY; Yang EJ; Lee NH; Hyun CG
    J Gen Appl Microbiol; 2009 Feb; 55(1):63-8. PubMed ID: 19282635
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibiotic sensitivity of Corynebacterium acnes].
    Füzi M
    Orv Hetil; 1974 Jun; 115(22):1268-70. PubMed ID: 4276912
    [No Abstract]   [Full Text] [Related]  

  • 11. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C; Ergin S; Kaleli I; Kaçar N; Sengül M; Erdoğan BS
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibacterial activity of long-chain polyunsaturated fatty acids against Propionibacterium acnes and Staphylococcus aureus.
    Desbois AP; Lawlor KC
    Mar Drugs; 2013 Nov; 11(11):4544-57. PubMed ID: 24232668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS; Darwish YW
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance of Propionibacterium acnes in acne vulgaris.
    Swanson JK
    Dermatol Nurs; 2003 Aug; 15(4):359-62. PubMed ID: 14515616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
    Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
    Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Bowe WP; Filip JC; DiRienzo JM; Volgina A; Margolis DJ
    J Drugs Dermatol; 2006 Oct; 5(9):868-70. PubMed ID: 17039652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.